Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
Clemens Warnke1, Heinz Wiendl2, Hans-Peter Hartung1, Olaf Stüve3, Bernd C Kieseier11Department of Neurology, Heinrich-Heine University Düsseldorf, Germany; 2Department of Neurology – Inflammatory Disorders of the Nervous System and Neurooncology, University of Mü...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010-06-01
|
| Seri Bilgileri: | Drug Design, Development and Therapy |
| Online Erişim: | http://www.dovepress.com/identification-of-targets-and-new-developments-in-the-treatment-of-mul-a4614 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|